Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs Satellos Bioscience Inc. (MSLE)

Compass Therapeutics, Inc. and Satellos Bioscience Inc. are both Biotechnology companies. Satellos Bioscience Inc. is the larger, with a market value of $152.6M against $136.7M — 1.1× the size. Across the 8 metrics below, Satellos Bioscience Inc. leads on 5 and Compass Therapeutics, Inc. on 3.

Valuation

Metric CMPX MSLE Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.86 2.50 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.40 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (52.63%) (27.50%) (32.88%)
Free cash flow yield (39.71%) (19.37%) (23.13%)

Profitability

Metric CMPX MSLE Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.66%) (70.45%) (51.96%)
Return on assets (47.87%) (64.76%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX MSLE Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (16.67%) 21.20% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX MSLE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 11.22 4.97
Net debt to EBITDA 2.86 1.05 1.01

Dividend

Metric CMPX MSLE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMPX MSLE Biotechnology median
Market cap 136.65m 152.57m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack